Upload Avatar (500 x 500)
姬燕晓
Basic Medical Sciences
武汉大学
湖北省
Language: 中文, 英语
翻译后
代谢性疾病
机制
蛋白质修饰
药物开发
抗体
小分子
基于靶点
研究
治疗
Areas of Focus
- 蛋白质翻译后修饰与代谢性疾病机制
- 基于靶点的抗体、小分子药物研发
Work Experience
- 2015-2017 博士后，武汉大学基础医学院
- 2017-2021 助理研究员，武汉大学中南医院
- 2021-至今 特聘研究员，武汉大学基础医学院
Academic Background & Achievements
- 2005-2009 生物工程本科：成都理工大学
- 2009-2015 遗传学博士：武汉大学
Publications
- A kinome screen reveals that Nemo-like Kinase is a key upstream regulator of hepatic gluconeogenesis, 姬燕晓等, 2021
- Hepatic Regulator of G protein Signaling 5 Ameliorates NAFLD by Suppressing TAK1-JNK/p38 Signaling, 王佳等, 2020
- Milk Fat Globule–Epidermal Growth Factor–Factor 8 Improves Hepatic Steatosis and Inflammation, 张立等, 2020
- Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes, 程晓等, 2020
- F-box/WD Repeat-Containing Protein 5 Mediates the Ubiquitination of Apoptosis Signal-Regulating Kinase 1 and Exacerbates Nonalcoholic Steatohepatitis in Mice, 白丽等, 2019
- Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3, 方俊等, 2019
- The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis, 姬燕晓等, 2018
- Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates, 王培兴等, 2017
- The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling, 姬燕晓等, 2016
- Suppressor of IKKvarepsilon is an essential negative regulator of pathological cardiac hypertrophy, 邓康强等, 2016
